384 related articles for article (PubMed ID: 32789002)
1. Recent developments in the treatment of Parkinson's Disease.
Stoker TB; Barker RA
F1000Res; 2020; 9():. PubMed ID: 32789002
[TBL] [Abstract][Full Text] [Related]
2. New pharmacological options for treating advanced Parkinson's disease.
Devos D; Moreau C; Dujardin K; Cabantchik I; Defebvre L; Bordet R
Clin Ther; 2013 Oct; 35(10):1640-52. PubMed ID: 24011636
[TBL] [Abstract][Full Text] [Related]
3. Subthalamic GAD gene transfer in Parkinson disease patients who are candidates for deep brain stimulation.
During MJ; Kaplitt MG; Stern MB; Eidelberg D
Hum Gene Ther; 2001 Aug; 12(12):1589-91. PubMed ID: 11529246
[TBL] [Abstract][Full Text] [Related]
4. Emerging Treatment Approaches for Parkinson's Disease.
Stoker TB; Torsney KM; Barker RA
Front Neurosci; 2018; 12():693. PubMed ID: 30349448
[TBL] [Abstract][Full Text] [Related]
5. Current and experimental treatments of Parkinson disease: A guide for neuroscientists.
Oertel W; Schulz JB
J Neurochem; 2016 Oct; 139 Suppl 1():325-337. PubMed ID: 27577098
[TBL] [Abstract][Full Text] [Related]
6. Parkinson's disease: Autoimmunity and neuroinflammation.
De Virgilio A; Greco A; Fabbrini G; Inghilleri M; Rizzo MI; Gallo A; Conte M; Rosato C; Ciniglio Appiani M; de Vincentiis M
Autoimmun Rev; 2016 Oct; 15(10):1005-11. PubMed ID: 27497913
[TBL] [Abstract][Full Text] [Related]
7. Non-dopaminergic treatments for motor control in Parkinson's disease.
Fox SH
Drugs; 2013 Sep; 73(13):1405-15. PubMed ID: 23917951
[TBL] [Abstract][Full Text] [Related]
8. Progression of motor and nonmotor features of Parkinson's disease and their response to treatment.
Vu TC; Nutt JG; Holford NH
Br J Clin Pharmacol; 2012 Aug; 74(2):267-83. PubMed ID: 22283961
[TBL] [Abstract][Full Text] [Related]
9. Progress in Dopaminergic Cell Replacement and Regenerative Strategies for Parkinson's Disease.
Chen W; Huang Q; Ma S; Li M
ACS Chem Neurosci; 2019 Feb; 10(2):839-851. PubMed ID: 30346716
[TBL] [Abstract][Full Text] [Related]
10. Effects of robot-assisted gait training on postural instability in Parkinson's disease: a systematic review.
Picelli A; Capecci M; Filippetti M; Varalta V; Fonte C; DI Censo R; Zadra A; Chignola I; Scarpa S; Amico AP; Antenucci R; Baricich A; Benanti P; Bissolotti L; Boldrini P; Bonaiuti D; Castelli E; Cavalli L; DI Stefano G; Draicchio F; Falabella V; Galeri S; Gimigliano F; Grigioni M; Jonsdottir J; Lentino C; Massai P; Mazzoleni S; Mazzon S; Molteni F; Morelli S; Morone G; Panzeri D; Petrarca M; Posteraro F; Senatore M; Taglione E; Turchetti G; Bowman T; Nardone A
Eur J Phys Rehabil Med; 2021 Jun; 57(3):472-477. PubMed ID: 33826278
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective approaches to halt Parkinson's disease progression.
Sola P; Krishnamurthy PT; Kumari M; Byran G; Gangadharappa HV; Garikapati KK
Neurochem Int; 2022 Sep; 158():105380. PubMed ID: 35718278
[TBL] [Abstract][Full Text] [Related]
12. Exercise and gait/movement analyses in treatment and diagnosis of Parkinson's Disease.
Burtscher J; Moraud EM; Malatesta D; Millet GP; Bally JF; Patoz A
Ageing Res Rev; 2024 Jan; 93():102147. PubMed ID: 38036102
[TBL] [Abstract][Full Text] [Related]
13. Treatment of Parkinson's Disease: Current Treatments and Recent Therapeutic Developments.
Wal A; Wal P; Vig H; Jain NK; Rathore S; Krishnan K; Srivastava A
Curr Drug Discov Technol; 2023; 20(5):e120523216834. PubMed ID: 37183475
[TBL] [Abstract][Full Text] [Related]
14. Pre-clinical Aspects and Contemporary Treatments of Parkinson's Disease.
Chhabra P; Rishabh ; Singla S; Choudhary S; Kohli S; Bansal N; Bansal S
CNS Neurol Disord Drug Targets; 2023 Oct; ():. PubMed ID: 37815179
[TBL] [Abstract][Full Text] [Related]
15. Disease modification in Parkinson's disease.
Henchcliffe C; Severt WL
Drugs Aging; 2011 Aug; 28(8):605-15. PubMed ID: 21812497
[TBL] [Abstract][Full Text] [Related]
16. Cardinal Motor Features of Parkinson's Disease Coexist with Peak-Dose Choreic-Type Drug-Induced Dyskinesia.
Goubault E; Nguyen HP; Bogard S; Blanchet PJ; Bézard E; Vincent C; Langlois M; Duval C
J Parkinsons Dis; 2018; 8(2):323-331. PubMed ID: 29843253
[TBL] [Abstract][Full Text] [Related]
17. Treatment options for postural instability and gait difficulties in Parkinson's disease.
Müller MLTM; Marusic U; van Emde Boas M; Weiss D; Bohnen NI
Expert Rev Neurother; 2019 Dec; 19(12):1229-1251. PubMed ID: 31418599
[No Abstract] [Full Text] [Related]
18. Nonpharmacological, nonsurgical treatments for freezing of gait in Parkinson's disease: A systematic review.
Delgado-Alvarado M; Marano M; Santurtún A; Urtiaga-Gallano A; Tordesillas-Gutierrez D; Infante J
Mov Disord; 2020 Feb; 35(2):204-214. PubMed ID: 31769904
[TBL] [Abstract][Full Text] [Related]
19. The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.
Veselý B; Antonini A; Rektor I
J Neural Transm (Vienna); 2016 Mar; 123(3):241-50. PubMed ID: 26483133
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous low-frequency deep brain stimulation of the substantia nigra pars reticulata and high-frequency stimulation of the subthalamic nucleus to treat levodopa unresponsive freezing of gait in Parkinson's disease: A pilot study.
Valldeoriola F; Muñoz E; Rumià J; Roldán P; Cámara A; Compta Y; Martí MJ; Tolosa E
Parkinsonism Relat Disord; 2019 Mar; 60():153-157. PubMed ID: 30241951
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
